Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3946 AL 3960

The Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins

Folger A, Wang Y.

Cells. 2021 Oct 21;10(11):2835. doi: 10.3390/cells10112835.

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB.

Pharmaceutics. 2021 Nov 8;13(11):1897. doi: 10.3390/pharmaceutics13111897.

Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies

Bhattacharyya N, Pandey V, Bhattacharyya M, Dey A.

Asian J Pharm Sci. 2021 Sep;16(5):533-550. doi: 10.1016/j.ajps.2021.02.006. Epub 2021 Apr 2.

Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders

Yadav DK.

Curr Top Med Chem. 2021;21(31):2814-2838. doi: 10.2174/1568026621666211201150217.

Chorea in Neuro-Behçet's Disease

Hamid M, Adan K, Satte A, Bourazza A.

Cureus. 2021 Oct 25;13(10):e19039. doi: 10.7759/cureus.19039. eCollection 2021 Oct.

Non-Ketotic Hyperglycemic Hemichorea-Hemiballismus in the Setting of Antipsychotics and Methamphetamine

Nelson CC, Ohnoutka C, Ulen M.

Cureus. 2021 Oct 28;13(10):e19094. doi: 10.7759/cureus.19094. eCollection 2021 Oct.

Validation of biomarkers in Huntington disease to support the development of disease-modifying therapies: A systematic review and critical appraisal scheme

Tang H, van Eimeren T, Sampaio C, Mestre TA.

Parkinsonism Relat Disord. 2021 Dec;93:89-96. doi: 10.1016/j.parkreldis.2021.10.013. Epub 2021 Oct 14.

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?

Hu D, Liu Z, Qi X.

Front Neurosci. 2021 Nov 12;15:746873. doi: 10.3389/fnins.2021.746873. eCollection 2021.

Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell

Shojaei Baghini S, Gardanova ZR, Zekiy AO, Shomali N, Tosan F, Jarahian M.

Front Bioeng Biotechnol. 2021 Nov 19;9:775309. doi: 10.3389/fbioe.2021.775309. eCollection 2021.

Molecular Strategies to Target Protein Aggregation in Huntington's Disease

Jarosińska OD, Rüdiger SGD.

Front Mol Biosci. 2021 Nov 12;8:769184. doi: 10.3389/fmolb.2021.769184. eCollection 2021.

Fortification methods of coenzyme Q10 in yogurt and its health functionality-a review

Sarma S, Derose S, Govindarajan N, Essa MM, Qoronfleh MW, Chidambaram SB, Al-Bulushi B.

Front Biosci (Schol Ed). 2021 Dec 3;13(2):131-140. doi: 10.52586/S557.

DNA Methylation in Huntington's Disease

Zsindely N, Siági F, Bodai L.

Int J Mol Sci. 2021 Nov 25;22(23):12736. doi: 10.3390/ijms222312736.

Innovative Therapeutic Approaches for Huntington's Disease: From Nucleic Acids to GPCR-Targeting Small Molecules

Komatsu H.

Front Cell Neurosci. 2021 Nov 26;15:785703. doi: 10.3389/fncel.2021.785703. eCollection 2021.

Hyperglycemic chorea

Sasaki T, Suzuki Y, Sato M.

Oxf Med Case Reports. 2021 Dec 11;2021(11):omab118. doi: 10.1093/omcr/omab118. eCollection 2021 Nov.

Hemichorea-Hemiballism as a Manifestation of Hyperglycemia

Maia M, Moreira AP, Gonçalves AI, Espírito Santo J, Araújo J.

Cureus. 2021 Nov 7;13(11):e19330. doi: 10.7759/cureus.19330. eCollection 2021 Nov.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias